| Product Code: ETC7227398 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
France`s import shipments of pregabalin in 2024 were primarily sourced from top exporting countries including Germany, Ireland, China, USA, and India. The Herfindahl-Hirschman Index (HHI) indicated a moderate concentration in the market. With a compound annual growth rate (CAGR) of 2.25% from 2020 to 2024, the sector experienced steady expansion. Notably, the growth rate surged to 7.79% in 2024 compared to the previous year, reflecting a significant uptick in demand or supply dynamics within the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Pregabalin Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 France Pregabalin Market - Industry Life Cycle |
3.4 France Pregabalin Market - Porter's Five Forces |
3.5 France Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 France Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 France Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in France |
4.2.2 Growing awareness about the benefits of pregabalin in managing neuropathic pain |
4.2.3 Rising geriatric population in France leading to higher demand for pain management medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drugs in France |
4.3.2 Presence of alternative treatment options for neuropathic pain |
4.3.3 Potential side effects and safety concerns associated with pregabalin use |
5 France Pregabalin Market Trends |
6 France Pregabalin Market, By Types |
6.1 France Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 France Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 France Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 France Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 France Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 France Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 France Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 France Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 France Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 France Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 France Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 France Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 France Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 France Pregabalin Market Import-Export Trade Statistics |
7.1 France Pregabalin Market Export to Major Countries |
7.2 France Pregabalin Market Imports from Major Countries |
8 France Pregabalin Market Key Performance Indicators |
8.1 Number of new prescriptions for pregabalin in France |
8.2 Patient adherence rates to pregabalin treatment |
8.3 Number of clinical trials and research studies conducted on pregabalin efficacy and safety |
8.4 Average time taken for regulatory approvals for pregabalin-related products |
8.5 Number of healthcare professionals trained or certified in prescribing pregabalin |
9 France Pregabalin Market - Opportunity Assessment |
9.1 France Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 France Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 France Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Pregabalin Market - Competitive Landscape |
10.1 France Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 France Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here